₹ 1,855.30
51.30 (2.84%)
A
Aurobindo Pharma
₹ 1,855.30
AUROPHARMA Financials Summary (Consolidated)
Aurobindo Pharma revenue increased 10.94% quarter-on-quarter to ₹10,396 Cr in Sep 2026, while net profit increased 8.90% quarter-on-quarter to ₹1,124 Cr. Compared to the same quarter last year, revenue is up 24.36% and net profit is up 32.51%. EPS for the quarter stood at ₹19.57, increased from ₹17.86 in the previous quarter and up from ₹14.61 a year ago.
Aurobindo Pharma Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of AUROPHARMA Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
AUROPHARMA Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






